GGHC
AUPH icon

Gilder Gagnon Howe & Co’s Aurinia Pharmaceuticals AUPH Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-179,090
Closed -$1.35M – 247
2022
Q3 		$1.35M Sell
179,090
-876
-0.5% -$7.58K 0.02% 188
2022
Q2 		$1.81M Sell
179,966
-17,969
-9% -$201K 0.03% 179
2022
Q1 		$2.45M Buy
197,935
+2,652
+1% +$41K 0.02% 215
2021
Q4 		$4.47M Buy
195,283
+3,969
+2% +$94K 0.03% 225
2021
Q3 		$4.23M Buy
191,314
+749
+0.4% +$11.9K 0.02% 261
2021
Q2 		$2.47M Buy
190,565
+5,740
+3% +$73.1K 0.01% 295
2021
Q1 		$2.4M Buy
184,825
+4,575
+3% +$66.4K 0.01% 272
2020
Q4 		$2.49M Buy
+180,250
New +$2.62M 0.01% 245

Other funds holding AUPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return